A detailed history of First Hawaiian Bank transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, First Hawaiian Bank holds 10,547 shares of CRL stock, worth $2.09 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
10,547
Previous 12,295 14.22%
Holding current value
$2.09 Million
Previous $2.54 Million 18.2%
% of portfolio
0.07%
Previous 0.09%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$187.96 - $245.29 $328,554 - $428,766
-1,748 Reduced 14.22%
10,547 $2.08 Million
Q2 2024

Jul 02, 2024

SELL
$206.39 - $268.73 $311,442 - $405,513
-1,509 Reduced 10.93%
12,295 $2.54 Million
Q1 2024

Apr 05, 2024

SELL
$203.52 - $273.43 $2,035 - $2,734
-10 Reduced 0.07%
13,804 $3.74 Million
Q4 2023

Jan 08, 2024

SELL
$164.52 - $238.84 $20,894 - $30,332
-127 Reduced 0.91%
13,814 $3.27 Million
Q3 2023

Oct 10, 2023

SELL
$194.44 - $217.61 $2,916 - $3,264
-15 Reduced 0.11%
13,941 $2.73 Million
Q2 2023

Jul 06, 2023

BUY
$183.71 - $210.25 $223,942 - $256,294
1,219 Added 9.57%
13,956 $2.93 Million
Q1 2023

Apr 18, 2023

SELL
$191.89 - $259.92 $1,727 - $2,339
-9 Reduced 0.07%
12,737 $2.57 Million
Q4 2022

Jan 12, 2023

BUY
$197.11 - $250.07 $175,033 - $222,062
888 Added 7.49%
12,746 $2.78 Million
Q3 2022

Oct 05, 2022

SELL
$182.44 - $250.54 $1,094 - $1,503
-6 Reduced 0.05%
11,858 $2.33 Million
Q2 2022

Jul 22, 2022

SELL
$204.13 - $302.4 $651,174 - $964,655
-3,190 Reduced 21.19%
11,864 $2.54 Million
Q1 2022

Apr 06, 2022

SELL
$255.51 - $362.11 $35,004 - $49,609
-137 Reduced 0.9%
15,054 $4.28 Million
Q4 2021

Jan 12, 2022

BUY
$351.38 - $448.68 $2.95 Million - $3.77 Million
8,406 Added 123.89%
15,191 $5.72 Million
Q3 2021

Oct 12, 2021

SELL
$372.64 - $458.3 $838,440 - $1.03 Million
-2,250 Reduced 24.9%
6,785 $2.8 Million
Q2 2021

Jul 08, 2021

BUY
$294.17 - $371.65 $793,964 - $1 Million
2,699 Added 42.6%
9,035 $3.34 Million
Q1 2021

Apr 09, 2021

SELL
$249.67 - $299.48 $7,739 - $9,283
-31 Reduced 0.49%
6,336 $1.84 Million
Q4 2020

Jan 12, 2021

SELL
$222.0 - $252.62 $253,524 - $288,492
-1,142 Reduced 15.21%
6,367 $1.59 Million
Q3 2020

Oct 06, 2020

SELL
$175.56 - $226.45 $277,033 - $357,338
-1,578 Reduced 17.37%
7,509 $1.7 Million
Q2 2020

Aug 05, 2020

SELL
$118.84 - $189.72 $161,265 - $257,450
-1,357 Reduced 12.99%
9,087 $1.59 Million
Q1 2020

Apr 21, 2020

BUY
$98.9 - $178.34 $591,916 - $1.07 Million
5,985 Added 134.22%
10,444 $1.32 Million
Q4 2019

Jan 13, 2020

SELL
$126.05 - $152.76 $121,764 - $147,566
-966 Reduced 17.81%
4,459 $682,000
Q3 2019

Oct 03, 2019

BUY
$125.07 - $143.67 $9,755 - $11,206
78 Added 1.46%
5,425 $718,000
Q2 2019

Jul 15, 2019

BUY
$123.4 - $148.55 $1,727 - $2,079
14 Added 0.26%
5,347 $759,000
Q1 2019

Apr 02, 2019

SELL
$104.82 - $146.73 $40,774 - $57,077
-389 Reduced 6.8%
5,333 $775,000
Q4 2018

Jan 11, 2019

SELL
$105.09 - $137.23 $6,410 - $8,371
-61 Reduced 1.05%
5,722 $647,000
Q3 2018

Oct 16, 2018

BUY
$112.11 - $134.54 $648,332 - $778,044
5,783 New
5,783 $778,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.